Page last updated: 2024-09-04

cilomilast and apremilast

cilomilast has been researched along with apremilast in 2 studies

Compound Research Comparison

Studies
(cilomilast)
Trials
(cilomilast)
Recent Studies (post-2010)
(cilomilast)
Studies
(apremilast)
Trials
(apremilast)
Recent Studies (post-2010) (apremilast)
162134261996586

Protein Interaction Comparison

ProteinTaxonomycilomilast (IC50)apremilast (IC50)
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)0.086
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.059
cAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)0.086
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.1235

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, W; Dong, G; Feng, C; Gu, Z; Li, H; Li, J; Li, M; Liu, H; Tang, W; Xu, Y; Zhang, R; Zhang, X; Zhu, F1
He, J; Ke, H; Peng, T; Qi, B; Shi, J1

Reviews

1 review(s) available for cilomilast and apremilast

ArticleYear
Advances in the Development of Phosphodiesterase-4 Inhibitors.
    Journal of medicinal chemistry, 2020, 10-08, Volume: 63, Issue:19

    Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Development; Drug Discovery; Humans; Molecular Structure; Phosphodiesterase 4 Inhibitors; Protein Conformation; Quinolones; Vomiting

2020

Other Studies

1 other study(ies) available for cilomilast and apremilast

ArticleYear
Structure-Aided Identification and Optimization of Tetrahydro-isoquinolines as Novel PDE4 Inhibitors Leading to Discovery of an Effective Antipsoriasis Agent.
    Journal of medicinal chemistry, 2019, 06-13, Volume: 62, Issue:11

    Topics: Animals; Caco-2 Cells; Catalytic Domain; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Design; Drug Evaluation, Preclinical; Female; HEK293 Cells; Humans; Male; Mice; Models, Molecular; Phosphodiesterase 4 Inhibitors; Psoriasis; Rats; Stereoisomerism; Structure-Activity Relationship; Tetrahydroisoquinolines; Tissue Distribution

2019